The effects of denosumab compared with oral bisphosphonates (BP) in patients with RA complicated with osteoporosis on the progression of structural damage, BMD and disease activity.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2016
Price : $35 *
At a glance
- Drugs Denosumab (Primary) ; Bisphosphonates
- Indications Osteoporosis; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms Two Birds
- 03 Aug 2016 Status changed from recruiting to discontinued.
- 17 Aug 2015 Planned End Date is 31 Mar 2017, according to University Hospital Medical Information Network - Japan record.
- 08 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan